Summary:
Study is only for people who, for at least the last 12 months, have been prescribed COPD maintenance triple therapy ( a combination of an anti-inflammatory inhaledmedication and two inhaled bronchodialator)
Qualified Participants Must:
• Be at least 40 years of age
• Have at least 1 year of COPD diagnosis
• Be current or former smoker
• Have had at least 1 COPD exacerbation in the past 12 months
Qualified Participants May Receive:
Compensation for time and travel; No insurance neccessary; Study related health care